Champions Oncology (CSBR) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.37% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 134.19% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 50.90% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -1.42% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 13.83% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | -6.83% |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -57.56% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -3.52% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.32% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3.52% |
| Apr 30, 2026 | -21.62% |
| Jan 31, 2026 | -15.10% |
| Oct 31, 2025 | -7.69% |
| Jul 31, 2025 | 8.43% |
| Apr 30, 2025 | 2.80% |
| Jan 31, 2025 | -28.34% |
| Oct 31, 2024 | -16.91% |
| Jul 31, 2024 | -10.25% |
| Apr 30, 2024 | -17.64% |
| Jan 31, 2024 | -15.39% |
| Oct 31, 2023 | -13.78% |
| Jul 31, 2023 | -10.97% |
| Apr 30, 2023 | 6.65% |
| Jan 31, 2023 | 52.52% |
| Oct 31, 2022 | 57.25% |
| Jul 31, 2022 | 54.37% |
| Apr 30, 2022 | 40.65% |
| Jan 31, 2022 | 38.01% |
| Jul 31, 2021 | 57.90% |